Dr. Meziadi is a plant biology expert and the developer of Core Biogenesis technology. With over 15 years of experience in both fundamental and applied research, he specializes in molecular plant systems and the application of plant biotechnology for agricultural innovation.

Gabriel D’Enjoy is an agronomist engineer with extensive experience in international agri-business, particularly in crop protection and biostimulants. He has led strategic and operational roles in product management, market development, and sales across Europe and globally. Fluent in five languages, he drives go-to-market strategies, builds strategic partnerships, and optimizes sales channels to enhance value and profitability in competitive agricultural markets.

Bernhard Grimmig comes with expert advice as a former formulation lead from Bayer Crop Science.  Bernhard will consult EPICS formulation strategy, regulation and scaling for our portfolio products.

Dr. Nykiforuk brings unique expertise in plant molecular farming and drug development.  With over 55 patents in biotechnology and biopharma, his career spans technical R&D, portfolio strategy, and the creation of scalable expression systems for high-value protein production and manufacture.

Thomas Laurent has over 10 years of experience of the Ex-CEO of Micropep, which raised over $60M during his tenure.  Thomase brings strong direction regarding EPICS Go-to-Market strategy, regulations and business development.

A globally recognized pioneer in plant epigenetics, Dr. Vaucheret has authored more than 135 peer-reviewed publications with more than 28000 citations and numerous scientific awards. His research has shaped the modern understanding of gene silencing and regulatory pathways in plant systems.

Joerg Rehbein has over 25 business experience, and as Ex-SVP Bayer Crop Science will provide advice on strategy, sustainability and scale.